Chronic diabetes conditions include type 1 diabetes and type 2 diabetes. Potentially reversible diabetes conditions include prediabetes and gestational diabetes. Prediabetes occurs when your blood sugar levels are higher than normal, but not high enough to be classified as diabetes. And prediabetes is often the precursor of diabetes unless appropriate measures are taken to prevent progression. Gestational diabetes occurs during pregnancy but may resolve after the baby is delivered.
November 28th 2024
Catch up on important diabetes news from November 2024.
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Utilization of SGLT2 Inhibitors in the Treatment of Cardiovascular Disease, Diabetes, and Chronic Kidney D...
1.5 Credits / Cardiology; Endocrinology, Diabetes & Metabolism; Nephrology
View More
Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered ...
1.5 Credit / Endocrinology, Diabetes & Metabolism
View More
Integrated Continuous Glucose Monitoring Implementation and Connectivity: Best Practices, Featuring a Powered ...
1.5 Credit / Endocrinology, Diabetes & Metabolism
View More
Reducing Barriers in Integrated Continuous Glucose Monitoring Use, Featuring Patient Counseling Video Vignette...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Reducing Barriers in Integrated Continuous Glucose Monitoring Use, Featuring Patient Counseling Video Vignette...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Integrated Continuous Glucose Monitoring: What’s New in 2024, Featuring a Device Demonstration and Patient Cou...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Integrated Continuous Glucose Monitoring: What’s New in 2024, Featuring a Device Demonstration and Patient Cou...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Strategies for Addressing Cardiovascular Disease, Diabetes, and Chronic Kidney Disease With SGLT2 Inhibitors
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Reducing Endocrinopathies of Immune Checkpoint Inhibitor Therapy: Management Strategies for Oncology Pharmacis...
1.0 Credit / Oncology, Endocrinology, Diabetes & Metabolism
View More
Foundations in Continuous Glucose Monitoring
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes
0.75 Credit / Endocrinology, Diabetes & Metabolism
View More
SimulatED: Using Continuous Glucose Monitoring Data to Improve Health Outcomes (Pharmacy Technician Credit)
0.75 Credit / Endocrinology, Diabetes & Metabolism
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Uncovering the Challenges in Treatment Pathways in AMD and DME
1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry
View More
Navigating Anti-Vascular Endothelial Growth Factor Therapy and Dosing Strategies
1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry
View More
Improving Patient Outcomes in AMD and DME Through the Integration of Specialty Pharmacy Care
1.0 Credit / Endocrinology, Diabetes & Metabolism, Ophthalmology & Optometry
View More
Best Practices for the Integration of Continuous Glucose Monitoring Within the Health System
1.5 Credits / Endocrinology, Diabetes & Metabolism
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
Best Practices for the Integration of Continuous Glucose Monitoring Devices Across Community Pharmacy Settings
1.5 Credits / Endocrinology, Diabetes & Metabolism
View More
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outc...
1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
View More
Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support I...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support I...
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting
1.0 Credit / Endocrinology, Diabetes & Metabolism
View More
Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care an...
1.0 Credit / Cardiology, Endocrinology, Diabetes, & Metabolism, Nephrology
View More
Assessing SGLT-2 Inhibitors in Patients with T2D, Cardiovascular Complications | AHA 2024
November 20th 2024Three research posters presented at the American Heart Association’s 2024 Scientific Sessions looked into the use of SGLT-2 inhibitors in patients with type 2 diabetes and cardiovascular complications.
GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status
October 1st 2024Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.
Slideshow: Diabetes and Mental Health, Diet and Exercise for Prevention of T2D
August 22nd 2024Recent research on diabetes has examined its bidirectional relationship with mental health, the significant increase in prevalence over the last decade, and how both diet and exercise can help prevent type 2 diabetes.